SCHEMBL5800604

SCHEMBL5800604

CCC(=O)CCCc1ccc(C)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
PLAAT3 P53816 1/20 0.49
PLAAT5 Q96KN8 1/20 0.49
PLAAT2 Q9NWW9 1/20 0.49
PLAAT4 Q9UL19 1/20 0.49
IAPP P10997 1/20 0.47
FFAR1 O14842 2/20 0.46
IGF1R P08069 1/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 2/20 0.44
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
SLC5A1 P13866 1/20 0.44
SLC5A2 P31639 1/20 0.44
CASP3 P42574 1/20 0.43
CASP7 P55210 1/20 0.43
ALDH1A1 P00352 3/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11390257 0.90 TDP1 (0.55) TDP1L3MBTL1PLAAT3PLAAT5PLAAT2
SCHEMBL105765 0.88 TDP1 (0.62) TDP1L3MBTL1PLAAT3PLAAT5PLAAT2
SCHEMBL22599471 0.87 IAPP (0.49) TDP1L3MBTL1PLAAT3PLAAT5PLAAT2
SCHEMBL22414097 0.85 ESR1 (0.55) PLAAT3PLAAT5PLAAT2PLAAT4IAPP
SCHEMBL27049124 0.83 MAOB (0.47) IAPPHSD17B10RXRARXRBRXRG
SCHEMBL8809801 0.83 HPGD (0.50) TDP1IAPPFFAR1HSD17B10SLC5A1
SCHEMBL3642535 0.82 HDAC1 (0.64) TDP1L3MBTL1PLAAT3PLAAT5PLAAT2
SCHEMBL30911279 0.81 PLAAT3 (0.47) TDP1L3MBTL1PLAAT3PLAAT5PLAAT2
SCHEMBL23842282 0.81 ALDH1A1 (0.56) HSD17B10ALDH1A1HPGDSLC6A3
Ammonia Solution, Strong SCHEMBL6014478 0.81 HDAC1 (0.62) TDP1L3MBTL1PLAAT3PLAAT5PLAAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230147021-A1 POLYSULFIDE STABILIZATION UNIVERSITY PUBLIC CORPORATION OSAKA (JP) 2023-05-11 US disclosed
US-20230147021-A1 POLYSULFIDE STABILIZATION UNIVERSITY PUBLIC CORPORATION OSAKA (JP) 2023-05-11 US disclosed
EP-1691811-A1 COMBINATION OF A SEDATIVE AND A NEUROTRANSMITTER MODULATOR, AND METHODS FOR IMPROVING SLEEP QUALITY AND TREATING DEPRESSION Sepracor, Inc. (US) 2006-08-23 EP disclosed
WO-2005060968-A1 COMBINATION OF A SEDATIVE AND A NEUROTRANSMITTER MODULATOR, AND METHODS FOR IMPROVING SLEEP QUALITY AND TREATING DEPRESSION SEPRACOR INC. (US) 2005-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230147021-A1 POLYSULFIDE STABILIZATION YWHAZ, YWHAH, PTPN21 TDP1 1911/4885L3MBTL1 2977/4885PLAAT3 4404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.